Lausanne, Switzerland, July 3, 2023 – AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations at ...
Seres has finalized the protocol for the Phase 2 study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) with the FDA and has advanced key study startup ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...
The MarketWatch News Department was not involved in the creation of this content. MIRAMAR, Fla., March 25, 2026 /PRNewswire/ -- DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a ...
The purpose of this undergraduate minor is to leverage Drexel’s unique strengths and leadership in this area to advance the education of the next generation of leaders in immune engineering. Students ...
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent allogeneic humanized mice, evading both the adaptive and innate immune ...
Morning Overview on MSN
Salk Institute declares 2026 the year of brain health — launches initiative to prevent Alzheimer’s through cardiovascular and immune research
Nearly 7 million Americans are living with Alzheimer’s disease, a number the Alzheimer’s Association projects will reach ...
The immune system is a complex response of various cells that detect and elicit mechanisms to eliminate disease. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results